11/25
08:07 am
ocul
Ocular Therapeutix (NASDAQ:OCUL) had its "buy" rating reaffirmed by analysts at HC Wainwright. They now have a $19.00 price target on the stock.
Low
Report
Ocular Therapeutix (NASDAQ:OCUL) had its "buy" rating reaffirmed by analysts at HC Wainwright. They now have a $19.00 price target on the stock.
11/5
03:07 pm
ocul
Ocular Therapeutix (NASDAQ:OCUL) had its "outperform" rating reaffirmed by analysts at Royal Bank Of Canada.
Low
Report
Ocular Therapeutix (NASDAQ:OCUL) had its "outperform" rating reaffirmed by analysts at Royal Bank Of Canada.
11/5
03:07 pm
ocul
Ocular Therapeutix (NASDAQ:OCUL) had its "outperform" rating reaffirmed by analysts at Royal Bank Of Canada.
Low
Report
Ocular Therapeutix (NASDAQ:OCUL) had its "outperform" rating reaffirmed by analysts at Royal Bank Of Canada.
11/5
08:07 am
ocul
Ocular Therapeutix (NASDAQ:OCUL) had its "buy" rating reaffirmed by analysts at Chardan Capital. They now have a $21.00 price target on the stock.
Low
Report
Ocular Therapeutix (NASDAQ:OCUL) had its "buy" rating reaffirmed by analysts at Chardan Capital. They now have a $21.00 price target on the stock.
11/5
07:41 am
ocul
Rating for OCUL
Low
Report
Rating for OCUL
10/3
07:41 am
ocul
Rating for OCUL
Low
Report
Rating for OCUL
10/3
07:41 am
ocul
Rating for OCUL
Low
Report
Rating for OCUL
10/2
08:31 am
ocul
Ocular Therapeutix (NASDAQ:OCUL) had its "buy" rating reaffirmed by analysts at Chardan Capital. They now have a $21.00 price target on the stock.
Low
Report
Ocular Therapeutix (NASDAQ:OCUL) had its "buy" rating reaffirmed by analysts at Chardan Capital. They now have a $21.00 price target on the stock.
10/2
08:28 am
ocul
Rating for OCUL
Medium
Report
Rating for OCUL
10/1
02:23 pm
ocul
Rating for OCUL
Low
Report
Rating for OCUL
10/1
02:23 pm
ocul
Rating for OCUL
Low
Report
Rating for OCUL
10/1
08:45 am
ocul
Rating for OCUL
Medium
Report
Rating for OCUL
10/1
08:45 am
ocul
Rating for OCUL
Medium
Report
Rating for OCUL
10/1
07:21 am
ocul
Ocular Therapeutix (NASDAQ:OCUL) had its "outperform" rating reaffirmed by analysts at Citigroup Inc..
Medium
Report
Ocular Therapeutix (NASDAQ:OCUL) had its "outperform" rating reaffirmed by analysts at Citigroup Inc..
9/15
08:06 am
ocul
Ocular Therapeutix (NASDAQ:OCUL) is now covered by analysts at Chardan Capital. They set a "buy" rating and a $21.00 price target on the stock.
Medium
Report
Ocular Therapeutix (NASDAQ:OCUL) is now covered by analysts at Chardan Capital. They set a "buy" rating and a $21.00 price target on the stock.
9/15
06:19 am
ocul
Rating for OCUL
Low
Report
Rating for OCUL
9/15
05:04 am
ocul
Ocular Therapeutix initiated with a Buy at Chardan
Low
Report
Ocular Therapeutix initiated with a Buy at Chardan